These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3391000)

  • 1. Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system.
    Koopmans R; Dingemanse J; Danhof M; Horsten GP; van Boxtel CJ
    Clin Pharmacol Ther; 1988 Jul; 44(1):14-22. PubMed ID: 3391000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of dosage time of midazolam on its pharmacokinetics and effects in humans.
    Koopmans R; Dingemanse J; Danhof M; Horsten GP; van Boxtel CJ
    Clin Pharmacol Ther; 1991 Jul; 50(1):16-24. PubMed ID: 1855349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
    Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
    Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.
    Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
    Clin Pharmacokinet; 1990 Mar; 18(3):245-53. PubMed ID: 2323155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling of electroencephalographic effects of midazolam in eight Chinese men.
    Lu JF; Chen G; Xiang BR; An DK
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):399-403. PubMed ID: 7717060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
    Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
    Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol.
    Tuk B; van Gool T; Danhof M
    J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):235-50. PubMed ID: 12449497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam.
    Tuk B; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):202-7. PubMed ID: 9435179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
    Mandema JW; Tukker E; Danhof M
    Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
    Mandema JW; Kuck MT; Danhof M
    J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
    Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
    Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.
    Cleton A; Mazee D; Voskuyl RA; Danhof M
    Br J Pharmacol; 1999 May; 127(1):227-35. PubMed ID: 10369477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
    Mandema JW; Tukker E; Danhof M
    J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 7-day exposure to midazolam on electroencephalogram pharmacodynamics in rats: a model to study multiple pharmacokinetic-pharmacodynamic relationships in individual animals.
    Laurijssens BE; Greenblatt DJ
    J Pharm Pharmacol; 2002 Jan; 54(1):77-86. PubMed ID: 11829133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.
    Greenblatt DJ; Ehrenberg BL; Gunderman J; Locniskar A; Scavone JM; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1989 Apr; 45(4):356-65. PubMed ID: 2702793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling acute tolerance to the EEG effect of two benzodiazepines.
    Ihmsen H; Albrecht S; Hering W; Schüttler J; Schwilden H
    Br J Clin Pharmacol; 2004 Feb; 57(2):153-61. PubMed ID: 14748814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.